Literature DB >> 28512503

Massive Oculomotor Nerve Enlargement: A Case of Presumed Schwannomatosis.

Laura Donaldson1, Ryan Rebello2, Amadeo Rodriguez1,2,3.   

Abstract

A 45-year-old man presented with a slowly progressive pupil-involving third nerve palsy. Magnetic resonance imaging (MRI) revealed a tubular lesion extending from the interpeduncular cistern through the cavernous sinus and into the left orbit where it branched into a superior and an inferior division, clearly outlining the anatomy of the third cranial nerve. Multiple other, less pronounced, enlarged cranial nerves were noted. The differential diagnosis included chronic inflammatory demyelinating polyneuropathy (CIDP), hereditary motor and sensory neuropathy (HMSN), neurofibromatosis (NF), and schwannomatosis. The absence of other muscle weakness and of sensory symptoms combined with normal peripheral nerve conduction studies effectively ruled out the hypertrophic polyneuropathies and pointed to a syndromic cause of multiple benign peripheral nerve sheath tumours (PNSTs). The authors are treating this case as presumed schwannomatosis, a syndrome similar to NF2 with much lower frequency of acoustic neuromas.

Entities:  

Keywords:  MRI; Oculomotor nerve; schwannomatosis

Year:  2017        PMID: 28512503      PMCID: PMC5417081          DOI: 10.1080/01658107.2017.1285319

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  4 in total

1.  Schwannoma of the oculomotor nerve.

Authors:  Kenji Ohata; Toshihiro Takami; Takeo Goto; Kenichi Ishibashi
Journal:  Neurol India       Date:  2006-12       Impact factor: 2.117

2.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

Review 3.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

Review 4.  MRI in hypertrophic mono- and polyneuropathies.

Authors:  K De Smet; M De Maeseneer; A Talebian Yazdi; T Stadnik; J De Mey
Journal:  Clin Radiol       Date:  2012-09-07       Impact factor: 2.350

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.